Anstice Susan, Strike Carol J, Brands Bruna
Centre for Addiction and Mental Health, Toronto, Ontario, Canada.
Subst Use Misuse. 2009;44(6):794-808. doi: 10.1080/10826080802483936.
Supervised methadone consumption is an important part of methadone maintenance treatment (MMT) but may contribute to stigma for clients. Data from qualitative interviews with MMT clients (n = 64) conducted in 2002-2003 in Canada were analyzed using thematic analytic methods. Three themes dominated clients' accounts of supervised consumption (convenient access to services, relationships with pharmacists and dispensing staff, and attributes of the dispensing space) and were interwoven with experiences of stigmatization. While some dispensing contexts may help clients manage a stigmatized identity, others confer or make visible this identity. Reducing stigmatizing experiences within dispensing environments may improve MMT outcomes and decrease barriers to treatment. The study's limitations are noted.
美沙酮监督服用是美沙酮维持治疗（MMT）的重要组成部分，但可能会给患者带来耻辱感。采用主题分析方法，对2002年至2003年在加拿大对美沙酮维持治疗患者（n = 64）进行的定性访谈数据进行了分析。三个主题主导了患者对监督服用的描述（服务获取便利、与药剂师及配药人员的关系以及配药空间的属性），并与耻辱感经历相互交织。虽然某些配药环境可能有助于患者应对被污名化的身份，但其他环境则赋予或凸显了这种身份。减少配药环境中的耻辱感经历可能会改善美沙酮维持治疗的效果，并减少治疗障碍。研究的局限性也已指出。
